Full access to Entrepreneur for $5
Subscribe

Pfizer changes the name of its vaccine

Pfizer-BioNTech's biological has received full FDA approval to apply to ages 16 and over.

By
This article was translated from our Spanish edition. Opinions expressed by Entrepreneur contributors are their own.

Pfizer-BioNTech's COVID-19 vaccine will change its name now that it has received full approval from the Food and Drug Administration (FDA).

Depositphotos.com

From now on the immunization of the pharmaceutical will be called Comirnaty . It is the only serum of its kind that receives a total green light in the United States, which could lead to it being marketed directly to the consumer.

As reported by Forbes , Janet Woodcock, the acting commissioner of this regulator, pointed out that with this final authorization, the US population “can be sure that this vaccine meets the FDA's gold standards in terms of safety, efficacy and quality. manufacturing ”.

It is not the first vaccine to change its name. In March this year, the Anglo -Swedish pharmaceutical company AstraZeneca announced that the vaccine against COVID-19 that it developed in conjunction with the British University of Oxford was renamed Vaxzevria .